Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app cut PICC complications? new study aims to find out.

NCT ID NCT06905119

Knowledge-focused Sponsor: Fundacion Miguel Servet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study looks at whether a smartphone app called SpadCare can help patients who have a PICC line (a thin tube for giving medicine or nutrition) take better care of it at home. About 201 adults will either use the app or get standard care. The goal is to see if app users have fewer problems like infections or blockages, and feel more involved in their own care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Smartphone application (SpadCare)
What this could lead to
If successful, this could show that a simple app helps patients avoid infections and other PICC-related problems, making home care safer.
What could go wrong
This is an early-stage, non-randomized study with only 201 participants. Results may not apply to everyone, and the app's benefit over standard care is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 201 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2023

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients \>18 years. * Sign the informed consent form. * Have a Smartphone and accept the use of the APP. * Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month. Exclusion Criteria: * Patients with limitations in the use of digital resources or lack of Smartphone. * Patients who do not want to install the APP on their Smartphone * Patients who do not authorize access to their Computerized Medical Record (HCI).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Administration, intravenous are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Catheter-Related Infections Hyperphagia Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Administration, intravenous Adverse effects Care givers Catheter-related infections Catheterization, central venous Catheterization, peripheral Central venous catheters Computers, handheld Delivery of health care Digital health Home infusion therapy Home nursing Infusions, intravenous Mobile applications Nursing Parenteral nutrition, home Patient education as topic Patient participation Self administration Smartphone Telemedicine User-computer interface Vascular access devices

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Universitario de Navarra

    RECRUITING

    Pamplona, Navarre, 31003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.